无症状性脑梗死患者Hcy水平及MTHFR基因C677T多态性的相关性研究
Association of Homocysteine Level and MTHFR Gene C677T Polymorphism with Asymptomatic Cerebral Infarction
摘要: 目的:探讨无症状性脑梗死(SBI)患者少见危险因素Hcy水平及MTHFR基因C677T多态性的相关性。方法:收集2014年1月至2020年2月就诊于克拉玛依市中心医院115例明确诊断为SBI患者及123例健康体检者,分为SBI组和非SBI组。使用统一标准化登记表记录既往病史,均完善MTHFR基因C677T多态性测定、Hcy水平测定(Hcy ≥ 15 umol为HHcy)、生化指标测定、头颅MRI、颈部血管超声等。结果:发现高血压、糖尿病、高脂血症、动脉粥样硬化斑块形成、吸烟、饮酒均是SBI组危险因素,差异具有统计学意义(P < 0.05)。MTHFR基因C677T多态性包括(CC、CT、TT),在SBI组中分别占28.70%、39.1%、32.2%。非SBI组中分别占36.6%、48.8%、14.6%。其中TT基因型在SBI组中明显高于非SBI组,差异有统计学意义(P = 0.002),Hcy水平在SBI组高于非SBI组,差异具有统计学意义(P = 0.005)。SBI相关危险因素多重Logistic回归分析发现TT基因型、HHcy (Hcy ≥ 15 umol/L)、高血压、吸烟差异有统计学意义(P < 0.05)。结论:SBI组TT基因型占比多于非SBI组,且差异具有统计学意义。SBI组Hcy水平高于非SBI组,差异有统计学意义。SBI组三种基因型中TT基因型人群的血浆Hcy水平高于非SBI组,差异有统计学意义。TT基因型、HHcy (Hcy ≥ 15 umol/L)、高血压、吸烟为SBI独立危险因素。
Abstract: Objective: To investigate the relationship between Hcy level and C677T polymorphism of MTHFR gene in patients with silent cerebral infarction (SBI). Methods: A total of 115 patients who were diagnosed as SBI patients and 123 healthy patients in Karamay Central Hospital from January 2014 to February 2020 were collected and divided into SBI group and non-SBI group. A unified standardized registration form was used to record the past medical history, and the MTHFR gene C677T polymorphism determination, Hcy level determination (Hcy ≥ 15 umol is HHcy), biochemical index determination, cranial MRI, cervical vascular ultrasound, etc. were perfected. Results: It was found that hypertension, diabetes, hyperlipidemia, atherosclerotic plaque formation, smoking, and alcohol consumption were all risk factors in the SBI group, and the difference was statistically significant (P < 0.05). The C677T polymorphisms of MTHFR gene include (CC, CT, TT), which accounted for 28.70%, 39.1%, and 32.2% in the SBI group, respectively. The non-SBI group accounted for 36.6%, 48.8%, and 14.6%. The TT genotype in the SBI group was significantly higher than that in the non-SBI group, and the difference was statistically significant (p = 0.002). The Hcy level in the SBI group was higher than that in the non-SBI group, and the difference was statistically significant (P = 0.005). Multiple Logistic regression analysis of SBI-related risk factors found that TT genotype, HHcy (Hcy ≥ 15 umol/L), hypertension, and smoking were statistically significant (P < 0.05). Conclusion: The proportion of TT genotype in SBI group is more than that in non-SBI group, and the difference is statistically significant. The Hcy level in SBI group was higher than that in non-SBI group, and the difference was statistically significant. The plasma Hcy level of TT genotype in SBI group was significantly higher than that of non-SBI group. TT genotype, HHcy (Hcy ≥ 15 umol/L), hypertension and smoking were independent risk factors of SBI.
文章引用:张炜, 梁文宝, 李建玲, 许风雷, 程纪龙, 高文, 冯微. 无症状性脑梗死患者Hcy水平及MTHFR基因C677T多态性的相关性研究[J]. 临床医学进展, 2020, 10(10): 2234-2240. https://doi.org/10.12677/ACM.2020.1010338

参考文献

[1] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国无症状脑梗死诊治共识[J]. 中华神经科杂志, 2018, 51(9): 92-698.
[2] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国各类主要脑血管病诊断要点2019[J]. 中华神经科杂志, 2019, 52(9): 710-715.
[3] 周丽萍, 乔羲, 刘毓刚, 等. 血清同型半胱氨酸及其代谢相关基因MTHFR多态性与缺血性脑卒中发生及预后的关系[J]. 标记免疫分析与临床, 2017, 24(3): 241-246.
[4] Meilán, A., Larrosa, D., Ramón, C., Cernuda-Morollón, E., Martínez-Camblor, P., Saiz. A., Santamarta, E., Pérez-Pereda, S. and Pascual, J. (2020) No Association between Migraine Frequency and White Matter Lesions and Silent Brain Infarctions: A Study in a Series of Chronic Migraine Women. European Journal of Neurology, 27, 1689-1696. [Google Scholar] [CrossRef] [PubMed]
[5] 岳伟, 吴昊, 石志鸿, 等. 血浆同型半胱氨酸水平与急性缺血性脑卒中患者的卒中复发及死亡关系的研究[J]. 中华神经医学杂志, 2016, 15(7): 654-659.
[6] 张磊, 罗国君, 唐春雷, 等. ABCD3评分结合血浆同型半胱氨酸测定评估短暂性脑缺血后短期卒中风险[J]. 中国循证心血管医学杂志, 2016, 8(2): 197-199.
[7] Azeem, F., Durrani, R., Zerna, C. and Smith, E.E. (2020) Silent Brain Infarctions and Cognition Decline: Systematic Review and Meta-Analysis. Journal of Neurology, 267, 502-512. [Google Scholar] [CrossRef] [PubMed]
[8] Choudhury, N.A., DeBaun, M.R., Ponisio, M.R., Jordan, L.C., Rodeghier, M., Pruthi, S. and McKinstry, R.C. (2017) Intracranial Vasculopathy and Infarct Recurrence in Children with Sickle Cell Anaemia, Silent Cerebral Infarcts and Normal Transcranial Doppler Velocities. British Journal of Haematology, 183, 324-326. [Google Scholar] [CrossRef] [PubMed]
[9] Nam, K.W., Kwon, H.M., Jeong, H.Y., Park, J.-H., Kwon, H. and Jeong, S.-M. (2019) High Triglyceride/HDL Cholesterol Ratio Is Associated with Silent Brain Infarcts in a Healthy Population. BMC Neurology, 19, Article No. 147. [Google Scholar] [CrossRef] [PubMed]
[10] Masada, K., Kuratani, T., Shimamura, K., et al. (2019) Silent Cerebral Infarction after Thoracic Endovascular Aortic Repair: A Magnetic Resonance Imaging Study. European Journal of Cardio-Thoracic Surgery, 55, 1071-1078. [Google Scholar] [CrossRef] [PubMed]
[11] Escudero-Martínez, I., Ocete, R.F., Mancha, F., et al. (2020) Prevalence and Risk Factors of Silent Brain Infarcts in Patients with AF Detected by 3T-MRI. Journal of Neurology, 267, 2675-2682. [Google Scholar] [CrossRef] [PubMed]
[12] Nam, K.W., Kwon, H.M., Jeong, H.Y., et al. (2019) Obesity without Metabolic Disorder and Silent Brain Infarcts in Aneurologically Healthy Population. International Journal of Obesity, 44, 362-367. [Google Scholar] [CrossRef] [PubMed]
[13] 陈荣波, 曾琼, 魏丽玲, 等. 无症状脑梗死患者胱抑素c、同型半胱氨酸和血脂的相关性分析[J]. 中华脑血管病杂志(电子版), 2013, 7(1): 382-385.
[14] Leung, L.Y., Han, P.K.J., Lundquist, C., et al. (2019) Patients’ Responses to Incidentally Discovered Silent Brain Infarcts—A Qualitative Study. Journal of Patient-Reported Outcomes, 3, Article No. 23. [Google Scholar] [CrossRef] [PubMed]
[15] Conen, D., et al. (2019) Relationships of Overt and Silent Brain Lesions with Cognitive Function in Patients with Atrial Fibrillation. Journal of the American College of Cardiology, 73, 989-999.
[16] Chi, X., Wang, X., Guo, Z., et al. (2018) Relationships between Blood Pressure Variability and Silent Cerebral Infarction in Patients with Primary Hypertension. Artery Research, 24, 40-46. [Google Scholar] [CrossRef
[17] Sepúlveda-Sánchez, J.M., Matía-Francés, R., Martínez-Salio, A., González-De la Aleja-Tejera, J., Rodríguez-Peña Marín, M. and Porta-Etessam, J. (2004). Homocysteine and Cerebrovascular Disease. Revista de Neurología, 38, 347-358.[CrossRef
[18] Méndez-González, J., Rodríguez-Millán, E. and Blanco-Vaca, J.J.F. (2010) Vitamin Treatments That Lower Homocysteine Concentration: Can They Decrease Cerebrovascular Disease in Primary Prevention? Revista de Neurología, 50, 235-244. [Google Scholar] [CrossRef
[19] Chen, Q.-R., Jiang, S.-Q. and Xu, X.-P. (2012) Polymorphism of Genes Encoding Homocysteine Metabolism-Related Enzymes and Risk for Cardio-Cerebrovascular Disease. Chinese Journal of Cardiovascular Diseases, 40, 801-803.
[20] Fanning Jonathon, P., Wong Andrew, A. and Fraser John, F. (2014) The Epidemiology of Silent Brain Infarction: A Systematic Review of Population-Based Cohorts. BMC Medicine, 12, Article No. 119. [Google Scholar] [CrossRef] [PubMed]
[21] Meschia, J.F., Bushnell, C., Boden-Albala, B., et al. (2014) Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke, 45, 3754-3832. [Google Scholar] [CrossRef
[22] 王宇琴, 冉隆梅, 李晴, 等. MTHFR基因多态性及血清Hcy水平与脑卒中发生的相关性研究[J]. 中华生物医学工程杂志, 2017, 23(2): 158-161.